Japanese Drug Regulator Approves Genmab Cancer Drug For Patients With Advanced Cervical Cancer

Genmab’s Tivdak wins Japan’s approval for advanced cervical cancer after a Phase 3 trial showed improved survival over chemotherapy.

read more